Cancers, Free Full-Text

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines - ScienceDirect

Detection of HPV-16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. - Abstract - Europe PMC

Cancer Free Posters for Sale

Download or order free information booklets

Cancer-Free, Third Edition by Bill Henderson - Audiobook

Cancer Cells vs Normal Cells

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization

Radical causes of cancer

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes, Breast Cancer Research

Working with Filters - My NCBI Help - NCBI Bookshelf

Breast Cancer Awareness Month - National Breast Cancer Foundation

Cancers, Free Full-Text

Destination Healthy Skin Toolkit - The Skin Cancer Foundation

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer